LaVoie’s LHS Fifteen-Slide Presentation® for 2026: Make Your Science Stick in the AI Era Returns to BIO 2026

Donna LaVoie and Elise Simard will show biotech leaders how to build investor-ready stories that are clear, memorable, and actionable.

BOSTON & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--LaVoie Strategic Communications Group, Inc., under its established LaVoieHealthScience practice, announced today that Founder and CEO Donna LaVoie and Spokesperson Trainer Elise Simard will present "The LHS Fifteen-Slide Presentation^® for 2026: Make Your Science Stick in the AI Era" at the BIO International Convention on Wednesday, June 24, from 4:15 to 5:15 p.m. PT in San Diego.

Returning by popular demand, the session will provide health and science executives with a practical framework for developing and delivering investor- and partner-ready presentations that drive understanding, engagement, and action. Built around LaVoie's proprietary LHS Fifteen-Slide Presentation^® methodology, the presentation will show attendees how to structure complex scientific stories so that investors, strategic partners, and other key stakeholders can quickly understand a company's value proposition and growth potential.

"Biotech companies are operating in an increasingly competitive communications environment, where attention is limited and AI is reshaping how information is consumed and shared," said Donna LaVoie, Founder and CEO of LaVoie Strategic Communications Group, Inc. "The companies that succeed are not necessarily those with the most data, but those that can communicate their science clearly, credibly, and memorably. This session is designed to help leaders do exactly that."

The presentation will explore the essential elements of a compelling company narrative, including:

• Defining and articulating a clear value proposition
• Demonstrating market urgency and unmet need
• Establishing scientific and clinical differentiation
• Communicating regulatory and commercialization pathways
• Building a credible financial narrative
• Applying AI-era messaging and delivery techniques that make complex science easier to understand, remember, and repeat

Using a realistic biotech case study, LaVoie and Simard will demonstrate how presentation structure, narrative sequencing, and delivery techniques work together to strengthen investor and business development conversations.

"Strong science alone is no longer enough," said Elise Simard, Spokesperson Trainer at LaVoie Strategic Communications Group, Inc. "Executives need to be able to translate complexity into clarity and create presentations that help audiences quickly understand why the opportunity matters, why the company is positioned to win, and why now is the right time to engage."

The BIO International Convention brings together thousands of biotechnology and life sciences leaders, investors, business development executives, policymakers, and patient advocates from around the world. The session is designed to provide attendees with immediately applicable tools they can use to strengthen corporate presentations, fundraising efforts, and strategic partnering discussions.

Session Details

The LHS Fifteen-Slide Presentation^® for 2026: Make Your Science Stick in the AI Era
Wednesday, June 24, 2026
4:15–5:15 p.m. PT
BIO International Convention
San Diego Convention Center

About LaVoie Strategic Communications Group, Inc.
Celebrating its 25 years in business, LaVoie Strategic Communications Group, Inc. advises healthcare, life sciences, and government organizations at critical inflection points, leading with strategic communications and advisory services. We support clients with tailored communications programs that strengthen visibility, build credibility, and reach audiences that matter most.

For more information, please visit LaVoie’s website and connect with us at http://lavoiegroup.com/ and connect with us on LinkedIn, X, and Facebook.